Abstract
Hepatic encephalopathy (HE) is a neuropsychiatric disorder that often occurs as a consequence of acute or chronic liver failure. Previous reports have suggested that alterations in amino acid neurotransmission, particularly glutamate, may play an important role in the pathogenesis of HE. The objectives of the present study were to test the hypothesis that extracellular glutamate concentration is increased during HE, and to determine if flumazenil, a benzodiazepine antagonist, alters the extracellular concentration of glutamate during HE. The experimental approach involved using microdialysis probes to measure rat hippocampal extracellular glutamate concentration. HE was brought about as a result of thioacetamide-induced liver failure. Thioacetamide produced behavioral and metabolic effects, such as somnolence, hyperventilation and hyperammonemia, consistent with stage three HE. Comparison with saline-treated rats demonstrated that HE was associated with a significant increase (p=0.010) in extracellular hippocampal glutamate concentration. Administration of flumazenil caused a transient increase in arousal level, but did not affect the increase in glutamate concentration (p=0.93). These results corroborate the theory that glutamate neurotransmission is altered during HE and suggest that the flumazenil arousal of HE rats is not mediated by a change in extracellular glutamate concentration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albrecht, J., and Faff, L. (1994). Astrocyte-neuron interactions in hyperammonemia and hepatic encephalopathy.Adv. Exp. Med. Biol. 358:45–54.
Asao, H., and Oji, K. (1968).Hepatocerebral degeneration, Charles C. Thomas, Springfield, IL.
Basile, A.S., Hughes, R.D., Harrison, P.M., Murata, Y., Pannell, L., Jones, A., Williams, R., and Skolnick, P. (1991). Elevated brain concentrations of 1,4-benzodiazepines in fulminant liver failure.N. Engl. J. Med. 325:473–478.
Bassett, M.L., Mullen, K.D., Skolnik, P., and Jones, E.A. (1987). Amelioration of hepatic encephalopathy by pharmacologic antagonists of the GABA A-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.Gastroenterology.93:1069–1077.
Bosman, D.K., Deutz, N.E.P., DeGraaf, A.A., VdHulst, R.W.N., Van Eljik, H.M.H., Bovee, W.M.M.J., Maas, M.A.W., Jorning, G.G.A., and Chamuleau, R.A.F.M. (1990). Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative1H-NMR spectroscopy and biochemical investigation.Hepatology.12:281–290.
Bosman, D.K., Van den Buijs, C.A., de Haan, J.G., Maas, M.A., and Chamuleau, R.A. (1991). Inverse benzodiazepine receptor agonists temporally restore hepatic encephalopathy in the rat.Gastroenterology.101:772–781.
Bures, J. (1976). Innate and motivated behaviour. In: Techniquesand Basic Experiments for the Study of Brain and Behavior. Elsevier North Holland Inc., New York. pp. 37–45.
de Knegt, R.J., Schalm, S.W., van der Rijt, C.C.D., Fekkes, D., Dalm, E., and Hekking-Weyma, I. (1994). Extracellular brain glutamate during acute liver failure and during hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis.J. Hepatology.20:19–26.
Faff-Michalak, L., and Albrecht, J. (1993). Hyperammonemia and hepatic encephalopathy stimulated rat cerebral synaptic mitochondrial glutamate dehydrogenase activity specifically in the direction of glutamate oxidation.Brain Res. 618:299–302.
Ferenci, P., Herneth, A., Puspok, A., and Steindl, P. (1994). Neuropharmacologic modulation of hepatic encephalopathy: experimental and clinical data.Adv. Exp. Med. Biol. 358:103–112.
Fonnum, F., and Hassel, B. (1995). Glutamate synthesis, metabolism, and uptake. In (T.W. Stone, ed).CNS Neurotransmitters and Neuromodulators: Glutamate. CRC Press Inc, Boca Raton FL, pp. 19–34.
Gooday, R., Hayes, P.C., Bzeizi, K., and O'Carroll, R.E. (1995). Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy.Psychopharmacol. 119:295–298.
Hawker, F. (1993).Critical Care Management: The Liver, W.B. Saunders Company, London.
Hilgier, W., Haugvicova, R., and Albrecht, J. (1991). Decreased potassium-stimulated release of [3H]D-aspartate from hippocampal slices distinguishes encephalopathy related to acute liver failure from that induced by simple hyperammonemia.Brain Res. 567:165–168.
Howard, C.D., and Seifert, C.F. (1993). Flumazenil in the treatment of hepatic encephalopathy.Ann. Pharmacother. 27:46–48.
Jones, E.A., Yurdaydin, C., and Basile, A.S. (1994). The GABA hypothesis - state of the art.Adv. Exp. Med. Biol. 358:89–112.
Lavoie, J., Giguere, J.F., Layrargues, G.P., and Butterworth, R.F. (1987). Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.J. Neurochem. 49:692–697.
Lombardi, G., Mannaioni, G, Leonardi, P, Cherici, G, Carla, V, and Moroni, F. (1994). Ammonium acetate inhibits ionotropic receptors and differentially affect metabotropic receptors for glutamate.J. Neural Trans. 97:187–196.
Maddison, J.E., Mickelthwaite, C., Watson, W.E.J., and Johnston, G.A.R. (1996). Synaptosomal and brain slice cerebrocortical [3H]L-glutamate uptake in a rat model of chronic hepatic encephalopathy.Neurochem. Int. 28:89–93.
Maddison, J.E., Watson, W.E.J., and Johnston, G.A.R. (1995). L-Glutamate and gamma-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy.Metab. Brain. Dis. 10:135–141.
Morris, J.C., and Ferrendelli, J.A. (1990). Metabolic encephalopathy. In Pearlman, A.L., and Collins, R.C. (eds.).Neurobiology of Disease, Oxford University Press, New York, pp. 356–379.
Mousseau, D.D., and Butterworth, R.F. (1994). Current theories on the pathogenesis of hepatic encephalopathy.Proc. Soc. Exp. Biol. Med. 206:329–344.
Norenberg, M.D. (1987). The role of astrocytes in hepatic encephalopathy.Neurochem. Pathol. 7:13–33.
Oppong, K.N.W., Bartlett, K., Record, C.O., and Mardini, H.A. (1995). Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat.Hepatology.22:553–558.
Paxinos, G., and Watson, C. (1986).The Rat Brain in Stereotaxic Coordinates, 2nd Edition, Academic Press Inc, San Diego.
Peeling, J., Shoemaker, L., Gauthier, T., Benarroch, A., Sutherland, G.R., and Minuk, G.Y. (1993). Cerebral metabolic and histological effects of thioacetamide-induced liver failure.Am. J. Physiol. 265: G572-G578.
Porter, W.R., Gudzinowicz, M.J., and Neal, R.A. (1979). Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat.J. Pharmacol. Exp. Ther. 208: 386–391.
Rao, V.L.R., Audet, R.M., and Butterworth, R.F. (1995). Selective alterations in extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.J. Neurochem. 65:1221–1228.
Rao, V.L.R., Murthy, C.R.K., and Butterworth, R.F. (1992). Glutamatergic synaptic dysfunction in hyperammonemic syndromes.Metab. Brain. Dis. 7:1–20.
Record, C.O. (1991). Neurochemistry of hepatic encephalopathy.Gut. 32:1261–1263.
Reynolds, J.D., and Brien, J.F. (1992). Ontogeny of glutamate and gamma-aminobutyric acid release in the hippocampus of the guinea pig.J. Dev. Physiol. 18:243–252.
Schousboe, A., and Frandsen, A. (1995). Glutamate receptors and neurotoxicity. In (T.W. Stone, ed).CNS Neurotransmitters and Neuromodulators: Glutamate. CRC Press Inc, Boca Raton FL, pp. 239–251.
Scollo-Lavizzaro, G. (1984). The anitconvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases.Eur. Neurol. 23:1–6.
Sharief, M.K., Sander, J.W., and Shorvon, S.D. (1993). The effect of of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study.Epilepsy Res. 15:53–60.
Swain, M.S., Bergeron, M., Audet, R., Blei, A.T., and Butterworth, R.F. (1992). Monitoring of neurotransmitter amino acids by mean of an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant liver failure.Hepatology.16:1028–1035.
Szerb, J.C. and Redondo, I.M. (1993). Astrocytes and the entry of circulating ammonia into the brain: effect of of fluoroacetate.Metab. Brain Dis. 8:217–234.
Traub, R.D., and Miles, R. (1991).Neuronal Networks of the Hippocampus. Cambridge University Press, United Kingdom.
van der Rijt, C.C.D., de Knegt, R.J., Schalm, S.W., Terpstra, O.T., and Mechelse, K. (1990). Flumazenil does not improve hepatic encephalopathy associated with ischemic liver failure in the rabbit.Metab. Brain Dis. 5:131–141.
Yudkoff, M., Nissim, I., Daikhin, Y., Lin, Z.P., Nelson, D., Pleasure, D., and Erecinska, M. (1993). Brain Glutamate Metabolism: neuronal-astroglial relationships.Dev. Neurosci. 15: 343–350.
Zimmermann, C., Ferenci, P., Piel, C., Yurdaydin, C., Ebner, J., Lassmann, H., Roth, E., and Hortnagi, H. (1989). Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.Hepatology.9:594–601.A1938001 00004 CS-SPJRNPDF [HEADSUP]
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McArdle, P., Penning, D.H., Dexter, F. et al. Flumazenil does not affect the increase in rat hippocampal extracellular glutamate concentration produced during thioacetamide-induced hepatic encephalopathy. Metab Brain Dis 11, 329–342 (1996). https://doi.org/10.1007/BF02029494
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02029494